IPCA Laboratories Ltd (IPCA) is a manufacturer and supplier of active pharmaceutical ingredients (APIs) and formulations. The company manufactures various formulations and APIs for various therapeutic segments. It offers products for pain, rheumatology, antimalarials and hair care therapy. IPCA has API manufacturing facilities located in Madhya Pradesh, Maharashtra, Gujarat, Andhra Pradesh, Sunderland, and North Carolina. It operates formulation facilities in Silvassa, Madhya Pradesh, Maharashtra, Uttaranchal, Sikkim and Gujarat among others. The company markets its products across the Americas, Africa, Asia, Australia, and Europe. IPCA is headquartered in Mumbai, Maharashtra, India.
Headquarters
India
Address
142 Ab, Kandivli Industrial Estate, Kandivli (West), Mumbai, Maharashtra, 400067
Website
www.ipca.com
Telephone
91 22 62105000
No of Employees
16,167
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
IPCALAB (NSE)
Revenue (2022)
$795.8M
7.1%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-46.7%
(2022 vs 2021)
Market Cap*
$4.1B
Net Profit Margin (2022)
XYZ
-50.2%
(2022 vs 2021)
* As of and is in US$
IPCA Laboratories Ltd premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Active Pharmaceutical Ingredients (APIs) | Services | Ace Revelol |
| Formulations | Clinical Research and Laboratory Testing Services | Acera |
| Acne | ||
| XYZ | ||
| XYZ | ||
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Acquisitions/Mergers/Takeovers | In September, the company acquired an additional 19.29% stake in Unichem Laboratories. |
| 2023 | Acquisitions/Mergers/Takeovers | In August, the company acquired 33.38% stake in Unichem Laboratories. |
| 2022 | Acquisitions/Mergers/Takeovers | In December, the company acquired 6.53% stake in Trophic Wellness. |
Competitor Comparison
| Key Parameters | IPCA Laboratories Ltd | Sun Pharmaceutical Industries Ltd | Aurobindo Pharma Ltd | Dr. Reddy's Laboratories Ltd | Cipla Ltd |
|---|---|---|---|---|---|
| Headquarters | India | India | India | India | India |
| City | Mumbai | Mumbai | Hyderabad | Hyderabad | Mumbai |
| State/Province | Maharashtra | Maharashtra | Telangana | Telangana | Maharashtra |
| No. of Employees | 16,167 | 41,000 | 15,690 | 24,832 | 26,615 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Premchand Godha | Managing Director; Chairman | Executive Board | 1983 | - |
| Pranay Godha | Chief Executive Officer; Managing Director | Executive Board | - | 50 |
| Ajit Kumar Jain | Joint Managing Director; Chief Financial Officer; Director | Executive Board | 2010 | - |
| Prashant Godha | Director | Executive Board | 2011 | - |
| E. J. Babu | President - API | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward